Literature DB >> 20577709

[Therapy of psychological and behavioral symptoms in dementia].

F Jessen1, A Spottke.   

Abstract

Behavioral and psychological symptoms of dementia (BPSD) represent a severe burden for patients and caregivers. The causes are disease-related neurobiological changes which increase the vulnerability to respond to external triggers with BPSD. Consequently, external factors (e.g. communication, milieu) are the primary target for treatment and also prevention of BPSD. Psychosocial interventions with the focus on the patient or on the caregivers are the core elements of BPSD therapy. If psychosocial interventions are not efficacious or only insufficiently applicable, pharmacological treatment may need to be initiated. Pharmacological treatment of BPSD has been less intensely investigated as treatment of cognition and function in dementia. However, recommendations can be given. This review follows the S3 guidelines on dementia published by the German Societies for Psychiatry and Psychotherapy (DGPPN) and Neurology (DGN) which address BPSD extensively.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20577709     DOI: 10.1007/s00115-010-3002-z

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  46 in total

Review 1.  Memantine for dementia.

Authors:  R McShane; A Areosa Sastre; N Minakaran
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

2.  Association of antipsychotics with mortality among elderly patients with dementia.

Authors:  Sudeep S Gill; Dallas P Seitz
Journal:  Am J Geriatr Psychiatry       Date:  2007-11       Impact factor: 4.105

3.  A prospective study of the effects of behavioral symptoms on the institutionalization of patients with dementia.

Authors:  Marjolein E de Vugt; Fred Stevens; Pauline Aalten; Richel Lousberg; Niek Jaspers; Frans R J Verhey
Journal:  Int Psychogeriatr       Date:  2005-09-27       Impact factor: 3.878

4.  Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

Authors:  Lon S Schneider; Karen Dagerman; Philip S Insel
Journal:  Am J Geriatr Psychiatry       Date:  2006-03       Impact factor: 4.105

5.  Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium.

Authors:  Philippe H Robert; Frans R J Verhey; E Jane Byrne; Catherine Hurt; Peter Paul De Deyn; Flavio Nobili; Roberta Riello; Guido Rodriguez; Giovanni B Frisoni; Magda Tsolaki; Nora Kyriazopoulou; Roger Bullock; Alistair Burns; Bruno Vellas
Journal:  Eur Psychiatry       Date:  2005-01-27       Impact factor: 5.361

6.  Risk of death in elderly users of conventional vs. atypical antipsychotic medications.

Authors:  Philip S Wang; Sebastian Schneeweiss; Jerry Avorn; Michael A Fischer; Helen Mogun; Daniel H Solomon; M Alan Brookhart
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

7.  Nighttime insomnia treatment and education for Alzheimer's disease: a randomized, controlled trial.

Authors:  Susan M McCurry; Laura E Gibbons; Rebecca G Logsdon; Michael V Vitiello; Linda Teri
Journal:  J Am Geriatr Soc       Date:  2005-05       Impact factor: 5.562

8.  A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.

Authors:  Clifford Singer; Rochelle E Tractenberg; Jeffrey Kaye; Kim Schafer; Anthony Gamst; Michael Grundman; Ronald Thomas; Leon J Thal
Journal:  Sleep       Date:  2003-11-01       Impact factor: 5.849

9.  A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia.

Authors:  A L Nyth; C G Gottfries; K Lyby; L Smedegaard-Andersen; J Gylding-Sabroe; M Kristensen; H E Refsum; E Ofsti; S Eriksson; S Syversen
Journal:  Acta Psychiatr Scand       Date:  1992-08       Impact factor: 6.392

Review 10.  Atypical antipsychotics for the treatment of delirious elders.

Authors:  Lauren B Ozbolt; Miguel A Paniagua; Robert M Kaiser
Journal:  J Am Med Dir Assoc       Date:  2008-01       Impact factor: 4.669

View more
  2 in total

1.  [Antipsychotics for treatment of neuropsychiatric disorders in dementia].

Authors:  H-J Gertz; G Stoppe; B Müller-Oerlinghausen; L G Schmidt; C Baethge; C Hiemke; K Lieb; T Bschor
Journal:  Nervenarzt       Date:  2013-03       Impact factor: 1.214

Review 2.  [Dementia: relevant aspects for otorhinolaryngologists].

Authors:  R Dodel; C Völter
Journal:  HNO       Date:  2020-03       Impact factor: 1.284

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.